Особенности хронической обструктивнойболезни легких у женщин

1. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future Trends. Lancet 2007; 370: 765–73.
2. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. Updated 2007 (www. goldcopd.com).
3. The global burden of disease. Update 2004 (www.who.int/healthinfo/global_burden_disease/2004_report_update/en/index).
4. Чучалин А.Г. Белая книга. Пульмонология. Россия 2003. М., 2003.
5. National Heart, Lung, and Blood Institute. Morbidity and mortality chartbook on cardiovascular, lung and blood diseases. Bethesda, Maryland: US Department of Health and Human Services, Public Health Service, National Institutes of Health, 2004.
6. Mannino DM, Homa DM, Akinbami LJ et al. Chronic obstructive pulmonary disease surveillance: United States, 1971–2000. MMWR Surveill Summ 2002; 51 (6): 1–16.
7. Soriano JR, Maier WC, Egger P et al. Recent trends in physician diagnosed COPD in women and men in the UK. Thorax 2000; 55: 789–94.
8. Feenstra TL, van Genugten ML, Hoogenveen RT et al. The impact of ageing and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands. Am J Respir Crit Care Med 2001; 164: 590–6.
9. Mathers DM, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3: e442.
10. Chapman KR. Chronic obstructive pulmonary disease: are women more susceptible than men? Clin Chest Med 2004; 25: 331–41.
11. Vestbo J. Epidemiology. In: Voelkel N.F., MacNee W., eds. Chronic obstructive lung disease. Hamilton, Canada, BC Decker Inc 2002; 41–55.
12. World Health Organization. Gender, health, and tobacco. Geneva, Switzerland: World Health Organization; 2003 (www.who.int).
13. Esson K, Leeder SR. The millennium development goals and tobacco control: an opportunity for global partnership. Geneva, Switzerland: World Health Organization; 2004.
14. Ernster V. Women and the tobacco epidemic: challenges for the 21st century. Geneva, Switzerland: World Health Organization; 2001.
15. Mackay J, Amos A. Women and tobacco. Respirology 2003; 8: 123–30.
16. The European Tobacco Control Report 2007. World Health Organization 2007; 153.
17. Xu X, Li B, Wang L. Gender difference in smoking effects on adult pulmonary function. Eur Respir J 1994; 7: 477–83.
18. Xu X, Weiss ST, Rijcken B, Shouten JP. Smoking, changes in smoking habits, and rates of decline in FEV1: new insight into gender differences. Eur Respir J 1994; 7: 1056–61.
19. Carter R, Nicotra B, Huber G. Differing effects of airway obstruction on physical work capacity and ventilation in men and women with COPD. Chest 1994; 106 (6): 1730–9.
20. Prescott E, Bjerg AM, Andersen PK et al. Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal study. Eur Respir J 1997; 10 (4): 822–7.
21. Han W, Pentecost BT, Pietropaolo RL et al. Estrogen receptor alpha increases basal and cigarette smoke extract-induced expression of CYP1A1 and CYP1B1, but not GSTP1, in normal human bronchial epithelial cells. Mol Carcinog 2005; 44: 202–11.
22. Ramirez-Venegas A, Sansores RH, Perez-Padilla R et al. Survival of patients with chronic obstructive pulmonary disease due to biomass smoke and tobacco. Am J Respir Crit Care Med 2006; 173: 393–7.
23. Dockery DW, Pope CA, Xu X et al. An association between air pollution and mortality in six US cities. N EngI J Mod 1993; 329: 1753–9.
24. Tao X, Hong CJ, Yu S et al. Priority among air pollution factors for preventing chronic obstructive pulmonary disease in Shanghai. Sci Total Environ 1992; 127: 57–67.
25. Pandey MR. Domestic smoke pollution and chronic bronchitis in a rural community of the Hill Region of Nepal. Thorax 1984; 39: 337–9.
26. Amoli K. Bronchopulmonary disease in Iranian housewives chronically exposed to indoor smoke. Eur Respir J 1998; 11: 659–63.
27. Dossing M, Khan J, al-Rabiah F. Risk factors for chronic obstructive lung disease In Saudi Arabia. Respir Med 1994; 88: 519–22.
28. Perez-Padilla R, Regalado U, Vedal S et al. Exposure to biomass smoke and chronic airway disease in Mexican women. Am J Respir Crit Care Med 1996; 154: 701–6.
29. Kanner RE, Connett JE, Altose MD et al. Gender difference in airway hyperresponsiveness in smokers with mild COPD: the Lung Health Study. Am J Respir Crit Care Med 1994; 150: 956–61.
30. Paoletti P, Carrozzi L, Viegi G et al. Distribution of bronchial responsiveness in a general population: effect of sex, age, smoking, and level of pulmonary function. Am J Respir Crit Care Med 1995; 151: 1770–7.
31. Becklake MR, Kauffmann F. Gender differences in airway behaviour over a human life span. Thorax 1999; 54: 1119–38.
32. Kelly RW, Illingworth P, Baldie G et al. Progesteron control of interleukin-8 production in endometrium and chorio-decidual cells underlines the role of the neutrophil in menstruation and parturition. Hum Reprod 1994; 9: 253–8.
33. Saetta M, Turato G, Maestrelli P et al. Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 1304–9.
34. Stoller JK, Aboussouan LS. Alpha-1-antitripsin deficiency. Lancet 2005; 365 (9478): 2225–36.
35. Lee P, Gildea TR, Stoller JK. Emphysema in nonsmokers: alpha 1-antitrypsin deficiency and other causes. Cleve Clin J Med 2002; 69: 928–46.
36. Wilson DO, Rogers RM, Wright EC et al. Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. Am Rev Respir Dis 1989; 139: 1435–8.
37. Lawlor DA, Ebrahim S, Davey Smith G. Association of birth weight with adult lung function. Thorax 2005; 60 (10): 851–8.
38. Varkey A. Cronic obstructive pulmonary disease in women: exploring gender differences. Curr Opin Pulm Med 2004; 10: 98–103.
39. Torday JS, Nielsen HC. The sex difference in fetal lung surfactant production. Exp Lung Res 1987; 1: 1–19.
40. Fleisher B, Kulovich MV, Hallman M, Gluck L. Lung profile: sex differences in normal pregnancy. Obstet Gyn 1985; 66: 327–30.
41. Thurlbeck WM. Postnatal human lung growth. Thorax 1982; 37: 564–71.
42. Quanjer PH, Borsboom GJ, Brunekreff B et al. Spirometric reference values for white European children and adolescents: Polgar revisited. Pediatr Pulmonol 1995; 19: 135–42.
43. Clausen JL, Coates AL, Quanjer PH. Measurement of lung volumes in humans: review and recommendations from an ATS/ERS workshop. Eur Respir J 1997; 10: 1205–6.
44. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144: 1202–18.
45. Хроническая обструктивная болезнь легких. (Федеральная программа). Практическое руководство для врачей. Издание 2-е, переработанное и дополненное. Под ред. А.Г.Чучалина. М., 2004.
46. Chapman KR, Tachkin DP, Pye DJ. Gender bias in the diagnosis of COPD. Chest 2001; 119: 1691–5.
47. Watson L, Vestbo J, Postma DS et al. Gender differenses in the management and experience of chronic obstructive pulmonary disease. Respir Med 2004; 98: 1203–7.
48. Pat G, Camp and Sarah M. Goring. Gender and the diagnosis, management, and surveillance of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2007; 4: 686–91.
49. de Torres JP, Casanova C, Hernandez C et al. Gender and COPD in patients attending a pulmonary clinic. Chest 2005; 128: 2012–6.
50. Di Marco F, Verga M, Reggente M et al. Anxiety and depression in COPD patients: the roles of gender and disease severity. Respir Med 2006; 100: 1767–74.
51. Watson L, Vonk JM, Lofdahl CG et al. Predictors of lung function and its decline in mild to moderate COPD in association with gender: results from the EUROSCOP study. Respir Med 2006; 100: 746–53.
52. Cydulka RK, Rowe BH, Clark S et al. Gender differences in emergency department patients with chronic obstructive pulmonary disease exacerbations. Acad Emerg Med 2005; 12: 1173–9.
53. Gift AG, Shepard CE. Fatigue and other symptoms in patients with chronic obstructive pulmonary disease: do women and men differ? J Obstet Gynecol Neonatal Nurs 1999; 28: 201–8.
54. Martinez FJ, Curtis JL, Sciurba F et al. Sex differences in severe pulmonary emphysema. Am J Respir Crit Care Med 2007; 176: 243–52.
55. Renkema TE, Schouten JP, Koeter GH, Postma DS. Effects of long-term treatment with corticosteroids in COPD. Chest 1996; 109: 1156–62.
56. Lee TA, Weiss KB. Fracture risk associated with inhaled corticosteroid use in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 169: 855–9.
57. Katsura H, Kida K. A comparison of bone mineral density in elderly female patients with COPD and bronchial asthma. Chest 2002; 122: 1949–55.
58. Scharf D, Shiffman S. Are there gender differences in smoking cessation, with and without bupropion? Pooled- and meta-analysis of clinical trials of bupropion SR. Addiction 2004; 99: 1462–9.
59. Krzyzanowski M, Robbins DR, Lebowitz MD. Smoking cessation and changes in respiratory symptoms in two populations followed for 13 years. Int J Epidemiol 1993; 22: 666–73.
60. Anthonisen N, Connet J, Kiley J et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1: the Lung Health Study. JAMA 1994; 272: 1497–505.
61. Scanlon PD, Connett JE, Waller LA et al. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med 2000; 161: 381–90.
62. Gritz ER, Nielsen IR, Brooks LA. Smoking cessation and gender: the influence of physiological, psychological, and behavioral factors. J Am Med Womens Assoc 1996; 51: 35–42.
63. Bjornson W, Rand C, Connett JE et al. Gender differences in smoking cessation after 3 years in the Lung Health Study. Am J Public Health 1995; 85: 223–30.
64. Panday S, Reddy SP, Ruiter R et al. Nicotine dependence and withdrawal symptoms among occasional smokers. J Adolesc Health 2007; 40: 144–50.
65. O'Hara P, Connett JE, Lee WW et al. Early and late weight gain following smoking cessation in the Lung Health Study. Am J Epidemiol 1998; 148 (9): 821–30.
66. Dales RE, Mehdizadeh A, Aaron SD et al. Sex differences in the clinical presentation and management of airflow obstruction. Eur Respir J 2006; 28: 319–22.
67. Ленней Дж., Иннс Дж.А., Кромптон Дж.К. Неправильное использование ингаляторов: оценка ингаляционной техники и предпочтений пациентов при сравнении семи различных ингаляционных устройств. Пульмонология. 2005; 4: 80–4.
68. Goodman DE, Israel E, Rosenberg M et al. The influence of age, diagnosis and gender on proper use of metered dose inhalers. Am J Respir Crit Care Med 1994; 150: 1256–61.
69. Vestbo J, Soriano JB, Anderson JA et al. Gender does not influence the response to the combination of salmeterol and fluticasone proprionate in COPD. Respir Med 2004; 98: 1045–50.
70. O'Donnell DE, Fluge T, Gerken F et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J 2004; 23: 832–40.
71. Convery RP, Leitch DN, Bromly C et al. Effect of inhaled fluticasone propionate on airway responsiveness in treatment-naive individuals-a lesser benefit in females. Eur Respir J 2000; 15: 19–24.
72. Decramer M, Celli B, Tashkin DP et al. Clinical trial design considerations in assessing long-term functional impacts of tiotropium in COPD: The Uplift Trial. COPD 2004; 1: 303–12.
73. Tashkin DP, Celli B, Senn S et ak. for the UPLIFT Study Investigators. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008; 359: 1543–54.
74. Decramer M, Rutten van Molken M. Dekhuijzen PN et al. Effect of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease: a randomized placebo-controlled trial. Lancet 2005; 365 (9470): 1552–60.
75. Cooper JD, Trulock EP, Triantafillou AN et al. Bilateral pneumonectomy (volume reduction) for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg 1995; 109: 106–19.
76. National Emphysema Treatment Trial Research Group. Patients at high risk of death after lung volume reduction surgery. N Engl J Med 2001; 345: 1075–82.
77. Haggerty MC, Stockdale-Woolley R, Zuwallack R. Functional status in pulmonary rehabilitation participants. J Cardiopulm Rehabil 1999; 19: 35–42.
78. Foy CG, Rejeski WJ, Berry MJ et al. Gender moderates the effects of exercise therapy on health-related quality of life among COPD patients. Chest 2001; 119: 70–6.